Clinical Trials Browser

Anxiety Disorders, Depression

NCT06801041 2026-03-03

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

Phase 2 Recruiting

20 enrolled

Anxiety Disorders, Depression, Neoplasms

NCT07336238 2026-02-09

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Phase 2 Not yet recruiting

18 enrolled

Anxiety Disorders, Depression, Neoplasm Metastasis

NCT06266611 2025-08-01

ARCTiC

Phase 2 Recruiting

185 enrolled

Anxiety Disorders, Depression, Pain

NCT06136546 2025-05-07

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Phase 2 Recruiting

100 enrolled

Depression, Depressive Disorder, Major, Inflammation, Cognitive Dysfunction

NCT02203552 2025-01-08

Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer

Phase 2 Completed

56 enrolled 9 charts

Breast

Anxiety Disorders, Breast Neoplasms, Depression

NCT05724849 2024-01-18

Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer

Phase 2 Withdrawn

Head & Neck

Depression, Head and Neck Neoplasms

NCT03410446 2022-05-06

Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care

Phase 2 Completed

22 enrolled

Depression, Neoplasms

NCT01466270 2021-10-20

Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction

Phase 2 Completed

62 enrolled 12 charts

Breast

Anxiety Disorders, Breast Neoplasms, Cognition Disorders, Depression, Fatigue, Sleep Wake Disorders

NCT00465595 2018-07-19

Psychopharmacology of Psilocybin in Cancer Patients

Phase 2 Completed

56 enrolled 8 charts

Anxiety Disorders, Depression, Neoplasms

NCT03205033 2017-07-02

Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy

Phase 2 Completed

36 enrolled

Breast

Breast Neoplasms, Depression, Pain, Sleep Disorders, Circadian Rhythm

NCT03063931 2017-02-27

Pain and Magnesium

Phase 2 Unknown

100 enrolled

Breast

Anxiety Disorders, Breast Neoplasms, Depression, Pain

NCT00005850 2016-07-04

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Phase 2 Completed

21 enrolled

Thoracic

Adenocarcinoma of Lung, Anxiety Disorders, Carcinoma, Non-Small-Cell Lung, Depression, Fatigue, Lung Neoplasms

NCT01680172 2016-02-29

Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer

Phase 2 Terminated

5 enrolled 6 charts

Anxiety Disorders, Depression, Neoplasms

NCT01748734 2015-06-04

Cognitive Therapy in Reducing Depression in Patients With Cancer

Phase 2 Completed

25 enrolled

Depression

NCT01510236 2015-05-28

U-CARE:TeenCan

Phase 2 Withdrawn

Anxiety Disorders, Depression, Neoplasms

NCT00706290 2014-06-06

Brief CBT for Anxiety and Advanced Cancer

Phase 2 Completed

49 enrolled

Anxiety Disorders, Depression, Neoplasm Metastasis, Neoplasms

NCT00069927 2014-02-03

Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression

Phase 2 Terminated

12 enrolled

Depression, Neurotoxicity Syndromes

NCT00424203 2013-09-04

Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

Phase 2 Completed

40 enrolled

Breast

Breast Neoplasms, Depression, Malnutrition

NCT00851669 2013-07-16

MEADOW/Bridge

Phase 2 Completed

91 enrolled

Endocrine

Alcoholism, Depression, Multiple Endocrine Neoplasia Type 1

NCT01507571 2012-01-11

DignityDK

Phase 2 Completed

80 enrolled

Depression, Neoplasms

NCT00186511 2006-12-05

Expanding Rural Access: Distance Delivery of Support

Phase 2 Completed

40 enrolled

Breast

Breast Neoplasms, Depression, Stress Disorders, Post-Traumatic

Clinical Trials

Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

ARCTiC

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer

Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer

Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care

Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction

Psychopharmacology of Psilocybin in Cancer Patients

Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy

Pain and Magnesium

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer

Cognitive Therapy in Reducing Depression in Patients With Cancer

U-CARE:TeenCan

Brief CBT for Anxiety and Advanced Cancer

Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression

Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

MEADOW/Bridge

DignityDK

Expanding Rural Access: Distance Delivery of Support